GE gets EU ok to buy Abbott's diagnostics units
This article was originally published in Clinica
Executive Summary
GE's proposed $8.13bn cash acquisition of Abbott's lab and point-of-care diagnostics businesses has received the greenlight from EU regulatory approval. The European Commission said in a statement that after careful examination, it concluded that the transaction would not significantly impede effective competition in the European Economic Area (EEA) or any substantial part of it". The deal has already been approved by the US Federal Trade Commission, but requires further clearances from other regions, a GE spokesperson told Clinica.